Showing results (21-30 of 279) with videos related to
Sort By:
Pageof 28
Anticancer Research|July 1, 1989
Somatostatin analogue SMS 201-995 reduces serum IGF-I levels in patients with neoplasms potentially dependent on IGF-IM N Pollak, C Polychronakos, H GuydaEuropean Journal of Cancer (Oxford, England : 1990)|September 11, 2014
Post-diagnostic use of beta-blockers and the risk of death in patients with prostate cancerJonathan Assayag, Michael N Pollak, Laurent AzoulayArchives of Internal Medicine|March 1, 1988
Successful intravenous immune globulin therapy for human immunodeficiency virus-associated thrombocytopeniaA N Pollak, J Janinis, D GreenThe Journal of the American Academy of Orthopaedic Surgeons|January 2, 2010
Extremity war injuries: collaborative efforts in research, host nation care, and disaster preparednessAndrew N Pollak, Col James R Ficke, Archives of Physical Medicine and Rehabilitation|October 1, 1996
Reliability and validity of the FIM for persons aged 80 years and above from a multilevel continuing care retirement communityN Pollak, W Rheault, J L StoeckerJEMS : a Journal of Emergency Medical Services|July 14, 2001
Helmet hazards. Do's & don'ts of football helmet removalD M Kleiner, A N Pollak, C McAdamJournal of Theoretical Biology|December 3, 2016
On the relationship between cell cycle analysis with ergodic principles and age-structured cell population modelsK Kuritz, D Stöhr, N Pollak, et al.Biophysical Journal|February 27, 2001
Time-resolved study of the inner space of lactose permeaseE Nachliel, N Pollak, D Huppert, et al.Biochemical and Biophysical Research Communications|July 15, 1988
Characterization of insulin-like growth factor I (IGF-I) receptors of human breast cancer cellsM N Pollak, C Polychronakos, S Yousefi, et al.Breast Cancer Research and Treatment|January 1, 1992
Tamoxifen reduces serum insulin-like growth factor I (IGF-I)M N Pollak, H T Huynh, S P LefebvrePageof 28